Minerva Neurosciences, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Boehringer Ingelheim International GmbH has filed an exit amendment to its Schedule 13D, reporting a beneficial ownership of 3.4% in Minerva Neurosciences, Inc. due to an increase in outstanding shares.
NASDAQ
Federated Hermes and affiliated entities have increased their beneficial ownership in Minerva Neurosciences, Inc. to 19.32% and committed to support a significant private placement.